Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway

Area of Science:

• Neuroscience
• Psychopharmacology

Background:

• Ketamine is an NMDA receptor antagonist with known psychotomimetic effects, but its precise neural mechanisms are not fully understood.
• Understanding ketamine's complex actions is crucial for its clinical applications and for studying psychosis models.

Purpose of the Study:

• To elucidate the neural mechanisms underlying ketamine's psychotomimetic effects at sub-anesthetic doses.
• To investigate the role of synaptic transmission and neurotransmitter systems in ketamine-induced behavioral changes.

Main Methods:

• In vivo electrophysiology in rats to measure cortical synaptic responses (hippocampus-mPFC evoked potentials).
• Behavioral assessment using prepulse inhibition (PPI) of acoustic startle response.
• Neurochemical analysis of dopamine levels and targeted lesions (6-OHDA) or receptor antagonists (SCH 23390, haloperidol, bicuculline).

Main Results:

• Ketamine dose-dependently decreased hippocampus-mPFC evoked potentials and induced PPI deficits at psychotomimetic doses.
• Ketamine increased mPFC dopamine levels, and these effects were abolished in dopamine-lesioned rats.
• Synaptic depression was blocked by a D1 receptor antagonist but not a D2 antagonist, and also prevented by a GABAA antagonist.

Conclusions:

• Ketamine, at psychotomimetic doses, depresses hippocampus-mPFC synaptic transmission.
• This depression is mediated by dopaminergic modulation via D1 receptors.
• The findings suggest a potential augmentation of GABAA receptor-mediated inhibition contributing to ketamine's psychotomimetic effects.